UPDATED May 20, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TSLA | US$343.82 | 0.5% | 84.3% | US$1.1t | US$295.81 | PE181.3x | E27.5% | n/a | Automobiles | ||
UNH | US$321.58 | 1.8% | -38.6% | US$286.6b | US$408.44 | PE13.2x | E9.2% | 2.6% | Healthcare | ||
BABA | US$125.16 | 1.8% | 45.3% | US$279.1b | US$162.41 | PE15.8x | E10.0% | 0.8% | Retail | ||
AVGO | US$231.68 | 0.5% | 65.6% | US$1.1t | US$239.25 | PE104.8x | E26.9% | 1.0% | Semiconductors | ||
GILD | US$109.11 | 2.8% | 62.1% | US$132.1b | US$115.04 | PE22.8x | E11.1% | 2.9% | Pharmaceuticals & Biotech | ||
AS | US$37.37 | 19.1% | 153.2% | US$17.4b | US$34.67 | PE102.5x | E26.6% | n/a | Consumer Durables | ||
PFE | US$23.52 | 2.3% | -17.6% | US$130.8b | US$29.45 | PE17x | E6.5% | 7.3% | Pharmaceuticals & Biotech | ||
JNJ | US$153.66 | 0.8% | 1.6% | US$366.9b | US$169.18 | PE17x | E1.5% | 3.4% | Pharmaceuticals & Biotech | ||
TINV | US$36.50 | 213.8% | 261.0% | US$1.3b | n/a | PE-151.2x | n/a | n/a | Diversified Financials | ||
JPM | US$265.68 | 0.3% | 33.2% | US$736.1b | US$266.19 | PB2.2x | E-3.1% | 2.1% | Banks | ||
AEM | US$112.57 | 4.0% | 60.5% | US$54.4b | US$126.38 | PE23.9x | E1.6% | 1.4% | Materials | ||
PG | US$165.64 | 0.5% | -1.6% | US$386.3b | US$171.51 | PE25.5x | E5.6% | 2.6% | Household | ||
ELV | US$412.49 | 2.1% | -24.4% | US$91.2b | US$505.44 | PE15.8x | E13.8% | 1.7% | Healthcare | ||
REGN | US$614.79 | 3.1% | -38.1% | US$63.0b | US$797.21 | PE14.4x | E7.4% | 0.6% | Pharmaceuticals & Biotech | ||
ORCL | US$160.31 | 0.4% | 28.6% | US$447.7b | US$178.12 | PE37x | E16.6% | 1.2% | Software | ||
MRK | US$77.97 | 1.0% | -40.4% | US$193.9b | US$101.91 | PE11.2x | E7.5% | 4.2% | Pharmaceuticals & Biotech | ||
BA | US$207.67 | 1.2% | 12.4% | US$154.8b | US$208.86 | PS2.3x | E82.4% | 0% | Capital Goods | ||
CRWV | US$90.24 | 4.2% | n/a | US$41.6b | US$65.00 | PS16x | E69.8% | n/a | Software | ||
VRTX | US$447.18 | 1.5% | 1.2% | US$113.2b | US$500.30 | PS10.3x | E31.1% | n/a | Pharmaceuticals & Biotech | ||
D | US$58.00 | 3.2% | 7.5% | US$47.9b | US$59.18 | PE22.7x | E9.9% | 4.6% | Utilities | ||
NEM | US$52.30 | 2.7% | 18.8% | US$56.6b | US$62.89 | PE11.6x | E-3.0% | 1.9% | Materials | ||
SO | US$90.83 | 1.5% | 13.9% | US$98.3b | US$91.86 | PE21.7x | E6.8% | 3.2% | Utilities | ||
PM | US$174.12 | 0.5% | 73.7% | US$269.5b | US$173.33 | PE35.8x | E13.2% | 3.1% | Food, Beverage & Tobacco | ||
BMY | US$47.87 | 1.4% | 13.2% | US$96.1b | US$57.19 | PE18x | E7.3% | 5.2% | Pharmaceuticals & Biotech |